Health insurer Cigna announced a new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs. The deal caps copays at $200 a month through employer healthcare programs.

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up spending, Mercer's latest survey reveals.

NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...

Cigna's pharmacy benefits unit struck deals with Novo Nordisk and Eli Lilly to limit the cost of weight-loss drugs. The agreements put a 15% annual cap on price increases for the weight-loss ...

Cigna on Thursday said it will limit how much health plans and employers spend on weight loss drugs each year in a bid to expand insurance coverage for those highly popular treatments. The move ...

Top of the morning to you. Gray skies are once again hovering over the soggy Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the ...

Evernorth Health Services, a Cigna subsidiary, introduces a financial guarantee in its EncircleRx program offering predictability for employers and health plans. Highlights agreements with Novo ...

Continuing high prices and demand for GLP-1 weight-loss drugs is creating lots of questions about the affordability of these drugs for U.S. healthcare consumers. For more than two years, drugs ...

Health insurer Cigna announced a new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs. The deal caps copays at $200 a month through employer healthcare programs.